Cargando…
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
Alzheimer’s disease is characterized by the extracellular accumulation of the amyloid β in the form of amyloid plaques and the intracellular deposition of the microtubule-associated protein tau in the form of neurofibrillary tangles. Most of the Alzheimer’s drugs targeting amyloid β have been failed...
Autores principales: | Mamun, Abdullah Al, Uddin, Md. Sahab, Mathew, Bijo, Ashraf, Ghulam Md |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059584/ https://www.ncbi.nlm.nih.gov/pubmed/31997800 http://dx.doi.org/10.4103/1673-5374.274329 |
Ejemplares similares
-
Combination Drug Therapy for the Management of Alzheimer’s Disease
por: Kabir, Md. Tanvir, et al.
Publicado: (2020) -
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018) -
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020) -
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
por: Uddin, Md. Sahab, et al.
Publicado: (2020)